Aurum Ventures backs Hebrew U diagnostic platform

medical research image: Shutterstock
medical research image: Shutterstock

Via Yissum Research Development Company, Aurum is investing $1.2 million in a new approach to early detection of disease.

Yissum Research Development Company of the Hebrew University of Jerusalem announced today that it has entered into a research agreement with Aurum Ventures MKI, the technology investment arm of Morris Kahn, for the development of a new diagnostic approach for early detection of multiple diseases by analyzing circulating DNA released from dying cells. Under the current agreement, Yissum is expected to receive $1.2 million funding. The novel technology will be presented at Yissum's booth during the IATI-BIOMED 2016 Conference, to be held on May 24-26, in Tel Aviv.

In a series of experiments involving hundreds of patients and control subjects, researchers developed a blood test that can detect multiple pathologies, including diabetes, cancer, traumatic injury and neurodegeneration, in a highly sensitive and specific manner. The novel method infers cell death in specific tissues from the methylation patterns of circulating DNA that is released by dying cells. The findings were reported in a paper published in March 2016 entitled "Identification of tissue specific cell death using methylation patterns of circulating DNA". The research was performed by a team led by Dr. Ruth Shemer and Prof. Yuval Dor from the Department of Developmental Biology and Cancer Research, Hebrew University of Jerusalem, and Prof. Benjamin Glaser, Head of Endocrinology Department, of the Hadassah Medical Center.

Yissum CEO Yaacov Michlin said, "The novel technology represents an exciting approach that opens up vast possibilities in diagnostic medicine. The capital received from Aurum Ventures will be used for the development of a diagnostic tool for selected diseases, with a first priority to neurodegenerative, cardiovascular and autoimmune diseases, as well as for developing the invention into a novel blood test for the early detection of multiple diseases at their asymptomatic stage."

"Prof. Dor and his team have developed a completely novel approach to early diagnosis of a variety of medical conditions that will enable detection of these diseases long before clinical signs of disease become evident," said Dr. Dan J. Gelvan, Managing Director of Life Science at Aurum Ventures. "This development is likely to become focal in future medicine and we are honored to have been offered the opportunity to join this path-breaking project."

Published by Globes [online], Israel business news - www.globes-online.com - on May 23, 2016

© Copyright of Globes Publisher Itonut (1983) Ltd. 2016

medical research image: Shutterstock
medical research image: Shutterstock
Israeli startup gems 2022 Globes names Finout "Most Promising Startup of 2025"

Cloud cost management solutions company Finout tops the list of Israeli startups most likely to succeed named by 80 local and foreign funds.

Mobileye CEO Amnon Shashua credit: Heinz Troll European Patent Office Mobileye posts strong Q1, reaffirms guidance despite tariffs

The Israeli advanced driving assistance systems company beat analysts' expectations on revenue and met expectations on non-GAAP net profit.

Xtend drones credit: Xtend Sentrycs teams with Xtend to strengthen drone security

The aim of the all-Israeli collaboration is to create a synergy of proven capabilities in a world where drones have become a major threat.

Intel Haifa  credit: Shutterstock Intel layoffs in Israel will benefit rivals

Industry experts agree that Intel staff dismissed in Israel will have no trouble finding work at rivals like Nvidia, as happened during last year's layoffs.

Ministry of Finance Jerusalem credit: Shutterstock Treasury sees Trump's tariffs cutting Israel's GDP growth

Amid the uncertainty that still surrounds the level of tariffs that would ultimately be imposed on Israeli goods, the annual damage to growth is estimated by the Finance Ministry at less than 0.5% of GDP.

French President Emmanuel Macron at the Paris Air Show in 2023 credit: Reuters Israel to scale down Paris Air Show presence

Due to President Emmanuel Macron's antagonism, Israel is reducing its presence at the exhibition, Ministry of Defense International Defense Cooperation Directorate (SIBAT) head Yair Kulas tells "Globes."

Jerusalem court cmplex credit: Zarhy Architects Tenders issued for two huge Jerusalem construction projects

The PFI tenders for the Gan Hotzvim tech campus and the courts complex include grants of NIS 1.7 billion for the winning bidders.

Israel Innovation Authority CEO Dror Bin Innovation Authority chief: Israel top for deep tech investment

Dror Bin told the Globes TECH IL conference that deep tech is the next wave for global tech and the rate of investment in Israel is the world's highest.

Gil Shwed and Nadav Zafrir credit: Menash Cohen With new CEO Check Point beats analysts in Q1

Revenue rose 6.5% and GAAP net profit rose 5% in Nadav Zafrir's first full quarter at the helm.

Tel Aviv light rail credit: Yossi Cohen Rishon Lezion to finance Red Line light rail extension

The Rishon Lezion Municipality will pay for part of the extension by marketing land above the planned underground depot.

Intel Haifa development center credit: Shutterstock Intel to cut 20% of workforce - report

"Bloomberg" reports that new CEO Lip-Bu Tan will announce the layoffs this week.

Healthee team credit: Healthee PR AI healthcare costs management co Healthee raises $50m

Healthee’s benefits and care navigation platform empowers employees and employers to make the most of their health benefits.

Former Shufersal CEO Itzik Abercohen credit: Eyal Izhar Competition Authority summons former Shufersal CEO to hearing

According to the indictment, Shufersal and Itzik Abercohen allegedly made public statements through which he attempted to reach arrangements to raise prices.

Reco founders Ofer Klein, Gal Nakash, and Tal Shapira credit: Elegant Photographics Israeli SaaS security co Reco raises $25m

The Tel Aviv-based company has developed a comprehensive application discovery engine capable of identifying and classifying over 50,000 applications, and providing visibility into an organization’s SaaS ecosystem.

Tel Aviv Stock Exchange credit: Tali Bogdanovsky TASE outperforms global markets in 2025

Boosted by the strong results of Israel's banks, the Tel Aviv Stock Exchange has demonstrated impressive resilience to domestic and foreign upheavals.

Metro credit: Bar Lavi Can Hyundai fill Metro vacuum created by China's exclusion?

The South Korean giant is reportedly eager to enter Israel's infrastructure sector but may not have the resources to dig the Metro tunnels.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018